Clinical Trial Update: Comparing Clinical Efficacy of One-Week Dual Delayed-Release Dexlansoprazole and Esomeprazole for GERD Grade A and B [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing the efficacy of a one-week dual delayed-release dexlansoprazole regimen versus esomeprazole for treating grade A and B gastroes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Dexilant (dexlansoprazole)
• Nexium (esomeprazole)

Snippet

Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital | Conditions: Gastroesophageal Reflux Disease | Phase 4 | Status: COMPLETED